ESAs are no longer indicated for use in cancer patients for chemotherapy-induced anemia if the intent of chemotherapy is to cure the patient. Medscape Medical News
How do the experts take tumor biology, efficacy and safety data, and patient preferences into account to optimize treatment for metastatic breast cancer? Medscape Hematology-Oncology
Dr. Daniel J. Weisdorf discusses the role of platelet transfusion and the criteria that newer treatments must satisfy to be of value in the treatment of thrombocytopenia in leukemia. Medscape Hematology-Oncology
This case presentation outlines the importance of effective antiemetic protection in the setting of moderately emetogenic cancer chemotherapy and highlights the challenges in achieving that goal. Medscape Hematology-Oncology
The authors provide an overview on the biological markers that can play a role in early bladder cancer detection and can perhaps subsequently reduce the need for frequent cystoscopies. Expert Review of Molecular Diagnostics
